Variables | All patients | Afatinib 30 mg daily | Afatinib 40 mg daily | P value |
---|---|---|---|---|
Initial response to afatinib treatment -n (%) | Â | Â | Â | 0.1661 |
 Complete response | 2 (1%) | 1 (1%) | 1 (1%) |  |
 Partial response | 138 (77%) | 75 (74%) | 63 (82%) |  |
 Stable disease | 35 (20%) | 25 (25%) | 10 (13%) |  |
 Progressive disease | 4 (2%) | 1 (1%) | 3 (4%) |  |
Disease control rate with afatinib treatment (%) | 175 (98%) | 101 (99%) | 74 (96%) | 0.1913 |
Response rate with afatinib treatment (%) | 140 (78%) | 76 (75%) | 64 (83%) | 0.1672 |